Add to a list

Inactive Instrument

Encision Inc. Share Price Other OTC

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	21.94L 19.21L 17.72L 16.55L 31.17L 21Cr 31.86L 2.13Cr 82.31L 10Cr 82.4L 80.59L 36Cr	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	32.51L 28.46L 26.25L 24.52L 46.18L 31Cr 47.2L 3.16Cr 1.22Cr 15Cr 1.22Cr 1.19Cr 53Cr	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	35.96%	Yield 2024 *	-	Yield 2025	-

13/12	Encision Inc. Announces Management Changes	CI
13/12	Encision Inc. Announces CEO Changes	CI
14/11	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
04/11	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
19/25/19	Encision Inc. announced that it has received $0.5 million in funding	CI
15/25/15	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
11/25/11	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
15/25/15	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/24/15	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
15/24/15	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
15/24/15	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/24/15	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/24/15	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

04/05	Encision Inc. Announces Halt of Stock Trading	AQ
13/04	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
30/01	Encision : Announces Decision to Deregister its Common Stock	PU
16/24/16	Encision : Reports First Quarter Fiscal Year 2025 Results Form 8 K	PU
24/23/24	Encision : Change in Certifying Accountants - Form 8-K	PU

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	08/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	01/08/2024
Denise Baker LAW	General Counsel	-	01/01/2019

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	01/01/1991
Robert Fries BRD	Director/Board Member	77	17/04/2024

Encision Inc. Share Price Other OTC

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Managers and Directors: Encision Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	-5.88%	-7.25%	-	-	25.32T
ABBOTT LABORATORIES	-1.50%	+4.86%	-31.01%	-13.85%	16TCr
MEDTRONIC PLC	-0.06%	+2.00%	-5.92%	-6.29%	10TCr
CENCORA, INC.	-1.57%	+3.61%	-5.93%	+48.46%	5.57TCr
HOYA CORPORATION	+0.90%	-5.29%	+52.20%	+53.60%	5.29TCr
BECTON, DICKINSON AND COMPANY	-0.47%	+7.79%	-9.17%	-40.09%	4.3TCr
MEDLINE INC.	+1.90%	+10.21%	-	-	3.29TCr
DEXCOM, INC.	-0.23%	-3.44%	-18.94%	-44.64%	2.71TCr
WEST PHARMACEUTICAL SERVICES, INC.	+1.09%	+8.15%	+62.05%	-3.94%	2.48TCr
STERIS PLC	-1.13%	+5.25%	-10.70%	-1.68%	2.1TCr
Average	-0.53%	+3.81%	+4.07%	-1.05%	5.83TCr
Weighted average by Cap.	+0.03%	+3.98%	-5.81%	-0.92%

	2024	2025
Net sales	65.86L 57.65L 53.17L 49.67L 93.54L 62Cr 95.62L 6.39Cr 2.47Cr 31Cr 2.47Cr 2.42Cr 106.64Cr	65.55L 57.38L 52.92L 49.44L 93.11L 62Cr 95.18L 6.36Cr 2.46Cr 31Cr 2.46Cr 2.41Cr 106.15Cr
Net income	-7L -6L -6L -5L -10L -6.54Cr -10.04L -67.15L -25.95L -3.23Cr -25.98L -25.41L -11Cr	-2L -2L -2L -2L -3L -2.08Cr -3L -21.37L -8L -1.03Cr -8L -8L -3.57Cr
Net Debt	12.91L 11.3L 10.42L 10L 18.33L 12Cr 18.74L 1.25Cr 48.41L 6.02Cr 48.47L 47.4L 21Cr	10.57L 9L 9L 8L 15.01L 9.99Cr 15.34L 1.03Cr 39.64L 4.93Cr 39.68L 38.81L 17Cr